#hypereosinophilia — Monday, June 01, 2026 (1 items)
| 0 | ℹ |
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.
(nature.com)
|
Nature Medicine 2026-06-01 | #clinical trial #immunotherapy #hypereosinophilia #eosinophil |